Nuria Illera
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics.
Journal: Frontiers in immunology
Published: January 16, 2026
Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation.
Journal: Journal of medical genetics
Published: June 01, 2025
Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion.
Journal: Molecular therapy. Nucleic acids
Published: December 23, 2024
Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study.
Journal: Experimental dermatology
Published: March 05, 2024
Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa.
Journal: The British journal of dermatology
Published: May 04, 2023
Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants.
Journal: JAMA dermatology
Published: March 02, 2022
FPR2 DNA Aptamers for Targeted Therapy of Wound Repair.
Journal: The Journal of investigative dermatology
Published: July 07, 2020
Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report.
Journal: Frontiers in medicine
Published: June 26, 2020
Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells.
Journal: Molecular therapy. Nucleic acids
Published: December 22, 2017
Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models.
Journal: The Journal of investigative dermatology
Published: November 13, 2014
Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies.
Journal: Experimental dermatology
Published: January 10, 2014
The regenerative potential of fibroblasts in a new diabetes-induced delayed humanised wound healing model.
Journal: Experimental dermatology
Published: January 19, 2013
Last Updated: 09/26/2026